NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/22/2024
Back to search
Official data from USPTO
PLASMA P.A.L.S.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PLASMA P.A.L.S.
ST13
US500000097976855Class
35, 44
Filing
97976855
Registration
7281098
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
09/22/2024
Trademark type
Word
Nice classes
35, 44
Filing date
04/19/2022
Registration date
01/16/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/16/2024
Last transaction
09/22/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2022-00-00
First use in commerce
2022-00-00
Drawing code
4
Owner type
03
Owner location
Edison, NJ, US
Examiner
BHANOT, KAPIL KUMAR
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CSL Plasma Inc.
Representatives
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting awareness of life saving blood plasma donationblood plasmablood conditionsblood treatment and immune deficiencies; Promoting the donation of blood plasma by means of arranging and conducting incentive reward and blood plasma donor loyalty programsadministration of an incentive reward and blood plasma donor loyalty program to promote blood plasma collection services and collection of blood plasma; Promoting public awareness of blood disorders and blood plasma and its treatment and impact on patients
Class 44
Medical information services; providing medical information and medical treatment information in the field of healthblood conditionsblood plasma and blood plasma donation; health care information services; Healthcare and healthcare information servicesproviding information concerning patient lifestyle and wellness for patientscaregiversparentsteacherscoaches and friends impacted by blood plasmablood plasma donationsblood conditionsblood treatment and immune deficiencies
Publications
History of USPTO decisions and trademark events.
25 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/16/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/16/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/13/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/12/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/14/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
11/14/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/03/2023
IUAF
USE AMENDMENT FILED
10/23/2023
DRRR
DIVISIONAL REQUEST RECEIVED
10/23/2023
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/23/2023
EISU
TEAS STATEMENT OF USE RECEIVED
10/23/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2023
PUBO
PUBLISHED FOR OPPOSITION
03/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/14/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/14/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/14/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/14/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/14/2023
DOCK
ASSIGNED TO EXAMINER
02/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/25/2022
NWAP
NEW APPLICATION ENTERED
04/22/2022
Continuous trademark protection
Get notified about every new filing that threatens PLASMA P.A.L.S. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.